Healthcare Media & Clinician Networks · Publisher & Media Owner
Everyday Health
Digital health publisher monetising audiences through healthcare advertising.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Everyday Health, Inc.
- Entity type
- COMPANY
- Headquarters
- United States
- Company size
- 501–1,000
- Market cluster / sector
- Healthcare Media & Clinician Networks
- Market role
- Publisher & Media Owner
- Official website
- everydayhealth.com
What Everyday Health does
The company operates an ad-supported digital publishing model. It attracts large consumer health audiences through medically reviewed editorial content, condition hubs, newsletters, interactive tools, and community experiences, then monetises that attention by selling advertising inventory and integrated marketing programmes to healthcare advertisers. Value creation depends on sustained audience trust, repeat engagement, and the ability to package condition-level intent and context into premium media offerings for brands and agencies.
Category differentiation
This company is a digital health publisher and media business, not a healthcare provider, insurer, or pharmaceutical manufacturer. It is also not a standalone public company today; it operates within Ziff Davis.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Everyday Health, Inc. is a US digital health publisher operating within Everyday Health Group, a division of Ziff Davis. It publishes medically reviewed health and wellness content for consumers and also operates community, directory, newsletter, and utility products such as symptom guidance, vaccine planning, and doctor search. Its portfolio and acquisition history show a broad health, pregnancy, parenting, and wellness media strategy spanning consumer and professional audiences. The company makes money primarily through advertising and media monetisation. It sells display, video, native, sponsored, and programmatic campaigns to pharmaceutical, biotech, healthcare, and agency buyers, using condition-specific audience targeting and first-party health audience data to support premium healthcare marketing programmes. End users consume content and tools for free, while advertisers fund the model.
Company news briefing
Briefing updated:
Everyday Health continues to expand its authoritative clinical and consumer health content to support Ziff Davis's diversified monetisation strategy. Recent developments include the release of its Metabolic Health Benchmark Report addressing national consumer knowledge gaps, alongside comprehensive reporting on major medical milestones such as label expansions for GLP-1 drugs like Mounjaro and weight-loss trial results for retatrutide. These initiatives reinforce the publisher's focus on high-utility multi-channel health insights.
Business model & monetisation
Everyday Health monetises through advertising-led digital publishing. Core revenue comes from selling display, video, and native advertising inventory across its health media properties. It also sells sponsored content, branded programmes, and programmatic campaigns to pharmaceutical, biotech, and healthcare brands, supported by first-party audience data and condition-based targeting. Newsletter distribution and broader media packaging extend campaign reach, while integrated marketing solutions create higher-value managed-service revenue.
- Display, video, and native advertising inventory
- Ad-Supported
- Sponsored content and branded programmes
- Service Fee
- Programmatic healthcare campaigns
- Ad-Supported
- Newsletter audience monetisation
- Ad-Supported
- Content syndication and packaged media extensions
- Service Fee
Products & capabilities
| Product | Description | Source |
|---|---|---|
| Everyday Health | Everyday Health is a large-scale digital health publishing platform delivering medically reviewed content, condition-specific hubs, wellness guidance, newsletters, and multimedia resources. It aggregates expert insights, patient stories, and interactive tools to attract a broad consumer audience and monetises primarily through advertising and sponsored content programmes. The platform operates as a core consumer media property within Everyday Health Group under Ziff Davis. |
|
| Symptom Checker | Symptom Checker is an interactive web-based diagnostic guidance tool that allows users to input symptoms and receive suggested next steps and potential treatment pathways. It is tightly integrated with Everyday Health editorial content to drive deeper engagement and guide users towards relevant medical information and care resources. |
|
| Vaccine Planner | Vaccine Planner is a personalised preventive care tool that generates tailored vaccination recommendations based on user inputs. It connects users with relevant educational resources and supports proactive health management through customised guidance. |
|
| Tippi | Tippi is a community-driven content platform that aggregates short-form tips and advice from patients and healthcare professionals. It provides actionable insights and real-world experiences that complement editorial content, increasing user engagement and retention. |
|
| Find a Doctor | Find a Doctor is a healthcare provider directory that enables users to search for nearby medical specialists and primary care physicians by category and location. It serves as a utility layer connecting content consumption with real-world healthcare access. |
|
| Community | Community is a peer-support platform where users share personal health experiences, coping strategies, and condition-specific advice. It strengthens audience engagement by enabling storytelling and user interaction within condition-focused groups. |
|
| Advertising Solutions | Advertising Solutions is Everyday Health Group’s commercial offering that connects pharmaceutical, biotech, and healthcare brands with targeted patient and provider audiences. It delivers data-driven marketing through native advertising, programmatic campaigns, and condition-based targeting using first-party health audience data. |
|
POLARIS7 WORKSPACE
Go deeper on Everyday Health and its market context
Access extended corporate structures, historical M&A and partnership links, technical footprint data, and automated Watchlist briefings grounded in primary sources.
- Corporate & subsidiary hierarchy
- Competitor & partner network
- Automated Watchlist briefings
Competitors & alternatives
Track competitor shifts
Receive automated telemetry on strategic moves, acquisitions, and market share shifts across Everyday Health's competitive landscape.
Digital health publisher with healthcare advertising and audience targeting assets.
Consumer health media and engagement platform with B2B health solutions.
Digital health publisher monetising consumer attention through advertising and sponsorships.
Medically reviewed digital health publisher for consumer audiences.
German healthcare publisher and digital services provider for medical audiences.
Side-by-side comparisons
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Everyday Health Survey Finds Widespread GLP-1 Satisfaction, New Opportunities for Long-Term Success
Product & Platform Launch · Recorded impact score: 3/5
Everyday Health has published findings from its survey on patient experiences with GLP-1 medications among individuals with obesity and type 2 diabetes. While over 80 percent of users report satisfaction and improved health metrics, significant gaps exist regarding long-term side effect guidance and provider communication. Everyday Health announced it is developing consumer resources to support patient education, healthcare providers, and health influencers across the GLP-1 journey.
- Ninety percent of U.S. adults are aware of GLP-1 medications for weight loss, and 15 percent report having used them.
- Eighty-two percent of current GLP-1 users with obesity report satisfaction with their treatment, and 88 percent with type 2 diabetes report improved blood sugar/A1C.
Buzzy GLP-1 Drug Retatrutide Led to Dramatic Weight Loss in Diabetes Trial
Product & Platform Launch
Everyday Health published an article on September 29, 2026 reporting that retatrutide, a GLP-1 drug, led to dramatic weight loss in a diabetes trial. The full article text was inaccessible due to a JavaScript-disabled error, so specific trial data could not be verified. The headline indicates significant weight loss outcomes associated with the drug.
- Everyday Health published an article on September 29, 2026 with the headline: 'Buzzy GLP-1 Drug Retatrutide Led to Dramatic Weight Loss in Diabetes Trial'.
- The article reports that retatrutide, a GLP-1 drug, led to dramatic weight loss in a diabetes trial.
Explore company relationships
Questions about Everyday Health
What is Everyday Health?
Everyday Health is a digital health publisher that provides medically reviewed health and wellness content, tools, newsletters, and community experiences.
Who uses Everyday Health?
Consumers, patients, and caregivers use its health information products, while pharmaceutical, biotech, healthcare marketers, and agencies buy its advertising solutions.
How does Everyday Health make money?
It makes money primarily by selling display, video, native, sponsored, and programmatic advertising and integrated healthcare marketing programmes.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
2 publicly documented primary sources and citations linked across the market graph.
Start with a company or market. Track what changes.
Create your Polaris7 workspace to explore extended company profiles, organize relevant players into Watchlists, and receive focused briefings when material changes occur.
Everyday Health
Open extended company details, ownership links, and automated signal monitoring in Polaris7.
